Logo image of AKBM.OL

AKER BIOMARINE ASA (AKBM.OL) Stock Earnings & Estimates

Europe - Euronext Oslo - OSL:AKBM - NO0010886625 - Common Stock

90 NOK
-0.9 (-0.99%)
Last: 12/10/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
AKBM.OL revenue by date.AKBM.OL revenue by date.
277.2M
5.78%
335.3M
20.96%
199M
-40.65%
228.14M
14.64%
260.17M
14.04%
286.25M
10.02%
619.85M
116.54%
682.44M
10.10%
750.08M
9.91%
EBITDA
YoY % growth
AKBM.OL ebitda by date.AKBM.OL ebitda by date.
73.5M
88.12%
53.7M
-26.94%
44.8M
-16.57%
44.2M
-1.34%
63.58M
43.85%
76.16M
19.79%
N/AN/AN/A
EBIT
YoY % growth
AKBM.OL ebit by date.AKBM.OL ebit by date.
22.1M
283.98%
1.4M
-93.67%
-3M
-314.29%
17.68M
689.33%
36.72M
107.69%
48.62M
32.41%
N/AN/AN/A
Operating Margin
AKBM.OL operating margin by date.AKBM.OL operating margin by date.
7.97%0.42%-1.51%7.75%14.11%16.99%N/AN/AN/A
EPS
YoY % growth
AKBM.OL eps by date.AKBM.OL eps by date.
0.07
248.94%
-0.04
-157.14%
N/A
227.50%
0.09
70.00%
0.24
178.44%
0.38
59.15%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25
EPS
Q2Q % growth
0.04
-54.67%
0.05
163.75%
Revenue
Q2Q % growth
60.18M
22.07%
61.88M
19.00%
EBITDA
Q2Q % growth
12.24M
-67.36%
13.94M
-71.02%
EBIT
Q2Q % growth
5.44M
988.00%
6.8M
2,166.67%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
0.06
100.00%
0.010.051,076.47%
Q4 2024
Q2Q % growth
-0.08
-144.44%
-0.01-0.07-684.31%
Q3 2024
Q2Q % growth
0.09
800.00%
0.040.05120.59%
Q2 2024
Q2Q % growth
0.03
200.00%
0.04-0.01-15.97%
Q4 2023
Q2Q % growth
0.18
500.00%
0.040.14341.18%
Q3 2023
Q2Q % growth
0.01
-80.00%
0.03-0.02-67.32%
Q2 2023
Q2Q % growth
-0.03
-133.33%
0.04-0.07-173.53%
Q1 2023
Q2Q % growth
-0.20
-100.00%
-0.10-0.10-96.08%
Q4 2022
Q2Q % growth
0.03
134.48%
0.10-0.07-70.59%
Q3 2022
Q2Q % growth
0.05
-72.22%
0.10-0.05-50.98%
Q2 2022
Q2Q % growth
0.09
325.00%
-0.040.13320.59%
Q1 2022
Q2Q % growth
-0.10 -0.140.0429.97%
Q4 2021
Q2Q % growth
-0.09
-151.18%
-0.150.0743.14%
Q3 2021
Q2Q % growth
0.18
500.00%
-0.090.27296.08%
Q2 2021
Q2Q % growth
-0.04 0.04-0.08-198.04%
Q1 2021
Q2Q % growth
-0.10 -0.100.00-3.20%
Q4 2020
Q2Q % growth
0.17 0.38-0.21-55.56%
Q3 2020
Q2Q % growth
0.03 0.06-0.03-46.52%
AKBM.OL Yearly EPS VS EstimatesAKBM.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 0.3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
55.3M
-41.17%
54.74M560K1.02%
Q1 2025
Q2Q % growth
50.8M
-35.12%
%
Q4 2024
Q2Q % growth
52M
-37.27%
56.78M-4.78M-8.42%
Q3 2024
Q2Q % growth
49.3M
-47.89%
56.78M-7.48M-13.17%
Q2 2024
Q2Q % growth
94M
6.09%
98.6M-4.6M-4.67%
Q1 2024
Q2Q % growth
78.3M
13.31%
%
Q4 2023
Q2Q % growth
82.9M
4.94%
89.76M-6.86M-7.64%
Q3 2023
Q2Q % growth
94.6M
39.32%
79.815M14.785M18.52%
Q2 2023
Q2Q % growth
88.6M
20.71%
84.405M4.195M4.97%
Q1 2023
Q2Q % growth
69.1M
21.44%
66.045M3.055M4.63%
Q4 2022
Q2Q % growth
79M
4.32%
87.04M-8.04M-9.24%
Q3 2022
Q2Q % growth
67.9M
9.57%
86.445M-18.545M-21.45%
Q2 2022
Q2Q % growth
73.4M
-1.16%
79.56M-6.16M-7.74%
Q1 2022
Q2Q % growth
56.9M
13.56%
54.57M2.33M4.27%
Q4 2021
Q2Q % growth
75.725M
0.30%
77.52M-1.795M-2.32%
Q3 2021
Q2Q % growth
61.969M
-11.70%
77.775M-15.806M-20.32%
Q2 2021
Q2Q % growth
74.263M
2.91%
74.8M-537K-0.72%
Q1 2021
Q2Q % growth
50.106M
-29.17%
59.84M-9.734M-16.27%
Q4 2020
Q2Q % growth
75.501M
4.97%
91.8M-16.299M-17.75%
Q3 2020
Q2Q % growth
70.183M
1.91%
92.82M-22.637M-24.39%
Q2 2020
Q2Q % growth
72.162M
9.05%
%
Q1 2020
Q2Q % growth
70.742M
80.43%
%
AKBM.OL Yearly Revenue VS EstimatesAKBM.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 6.25% -15%
Revenue0% 0% -0.59% -0.59%